COLOMA JASON V (Chief Executive Officer) sold 45.3% of their position (22.64K shares) of MAZE THERAPEUTICS, INC. on the open market
Open‑market sale worth $594.0K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 9/4/2026ACC: 0001676170-26-000022
DirectorOfficer· Chief Executive Officer
Since Mar 2026
-22.64K
Net shares
Net seller
$594.0K
Total sold
4
Open market trades
0B · 4S
4
Total transactions
22.64K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
−9.85K
Price / share
$26.38
Trade value
$259.86K
% of position
19.7%
9/2/2026
50K→40.15K
Common Stock
Direct
Shares
−1.38K
Price / share
$27.12
Trade value
$37.29K
% of position
3.4%
9/2/2026
40.15K→38.77K
Common Stock
Direct
Shares
−11.28K
Price / share
$26.01
Trade value
$293.48K
% of position
29.1%
9/3/2026
38.77K→27.49K
Common Stock
Direct
Shares
−129.00
Price / share
$25.77
Trade value
$3.32K
% of position
0.5%
9/3/2026
27.49K→27.36K
Total
Net shares
−22.64K
Net value
-$593.95K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/2/2026 | S · Sale | −9.85K | $26.38 | $259.86K | 19.7% | 50K | 40.15K |
| Common Stock Direct | 9/2/2026 | S · Sale | −1.38K | $27.12 | $37.29K | 3.4% | 40.15K | 38.77K |
| Common Stock Direct | 9/3/2026 | S · Sale | −11.28K | $26.01 | $293.48K | 29.1% | 38.77K | 27.49K |
| Common Stock Direct | 9/3/2026 | S · Sale | −129.00 | $25.77 | $3.32K | 0.5% | 27.49K | 27.36K |
| Total | −22.64K | -$593.95K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned18.15K
Common Stock
IndirectShares owned223.35K
Total
241.51K indirect241.51K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 18.15K | Indirect |
| Common Stock | 223.35K | Indirect |
| Total | 241.51K | 241.51K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported